利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

56 条记录 (耗时 0.024 秒)

    PHARMACEUTICAL PREPARATION CONTAINING A GESTAGEN, AND KIT AND METHOD FOR TREATING ENDOMETRIOSIS USING THE PREPARATION
    1.
    发明申请
    PHARMACEUTICAL PREPARATION CONTAINING A GESTAGEN, AND KIT AND METHOD FOR TREATING ENDOMETRIOSIS USING THE PREPARATION 审中-公开
    含有Gestagen的药物制剂，以及使用制剂治疗子宫内膜异位的药盒和方法

    公开(公告)号：US20080214512A1

    公开(公告)日：2008-09-04

    申请号：US12037990

    申请日：2008-02-27

    申请人： Christian Seitz ,  Annemarie Wasserfall ,  Holger Zimmermann

    发明人： Christian Seitz ,  Annemarie Wasserfall ,  Holger Zimmermann

    IPC分类号： A61K31/57 ,  A61P43/00

    CPC分类号： A61K31/57

    摘要： The pharmaceutical preparation for treating endometriosis contains at least 28, preferably 30, daily dose units, each of which contain dienogest, cyproterone acetate, or chlormadinone acetate at a daily dose that is at most twice that required to inhibit ovulation together with one or more pharmaceutical aids and/or carriers. The daily dose units are administered in a method of prophylaxis and/or therapy of endometriosis continuously during a time interval of at least 169 days or 25 weeks, preferably more than two years. The method effectively reduces endometriosis and associated pain, while undesirable side effects including bone density decrease are reduced or eliminated.

    摘要翻译： 用于治疗子宫内膜异位症的药物制剂含有至少28个，优选30个日剂量单位，每个剂量单位含有依那诺酯，乙酸环丙孕酮或醋酸氯美他尼酮，其日剂量为抑制排卵所需的一种或多种药物的两倍 辅助工具和/或承运人。 日剂量单位是在至少169天或25周，优选多于两年的时间间隔内连续预防和/或治疗子宫内膜异位症的方法施用的。 该方法有效地减少了子宫内膜异位症和相关的疼痛，而减少或消除包括骨密度降低在内的不期望的副作用。

    PHARMACEUTICAL PREPARATION CONTAINING A GESTAGEN, AND KIT AND METHOD FOR TREATING ENDOMETRIOSIS USING THE PREPARATION
    2.
    发明申请
    PHARMACEUTICAL PREPARATION CONTAINING A GESTAGEN, AND KIT AND METHOD FOR TREATING ENDOMETRIOSIS USING THE PREPARATION 审中-公开
    含有Gestagen的药物制剂，以及使用制剂治疗子宫内膜异位的药盒和方法

    公开(公告)号：US20110008409A1

    公开(公告)日：2011-01-13

    申请号：US12885919

    申请日：2010-09-20

    申请人： Christian Seitz ,  Annemarie Wasserfall ,  Holger Zimmermann

    发明人： Christian Seitz ,  Annemarie Wasserfall ,  Holger Zimmermann

    IPC分类号： A61F6/08 ,  A61K31/57 ,  A61K9/36 ,  A61P35/00

    CPC分类号： A61K31/57

    摘要： The pharmaceutical preparation for treating endometriosis contains at least 28, preferably 30, daily dose units, each of which contain dienogest, cyproterone acetate, or chlormadinone acetate at a daily dose that is at most twice that required to inhibit ovulation together with one or more pharmaceutical aids and/or carriers. The daily dose units are administered in a method of prophylaxis and/or therapy of endometriosis continuously during a time interval of at least 169 days or 25 weeks, preferably more than two years. The method effectively reduces endometriosis and associated pain, while undesirable side effects including bone density decrease are reduced or eliminated.

    摘要翻译： 用于治疗子宫内膜异位症的药物制剂含有至少28个，优选30个日剂量单位，每个剂量单位含有依那诺酯，乙酸环丙孕酮或醋酸氯美他尼酮，其日剂量为抑制排卵所需的一种或多种药物的两倍 辅助工具和/或承运人。 日剂量单位是在至少169天或25周，优选多于两年的时间间隔内连续预防和/或治疗子宫内膜异位症的方法施用的。 该方法有效地减少了子宫内膜异位症和相关的疼痛，而减少或消除包括骨密度降低在内的不期望的副作用。

    Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
    9.
    发明申请
    Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same 审中-公开
    口服避孕和口服治疗功能障碍性子宫出血的组合制剂，含有戊酸雌二醇和dienogest及其使用方法

    公开(公告)号：US20070088011A1

    公开(公告)日：2007-04-19

    申请号：US11377693

    申请日：2006-03-16

    申请人： Susan Zeun ,  Pol Boudes ,  Angelo Secci ,  Jan Endrikat ,  Holger Zimmermann

    发明人： Susan Zeun ,  Pol Boudes ,  Angelo Secci ,  Jan Endrikat ,  Holger Zimmermann

    IPC分类号： A61K31/57 ,  A61K31/56

    CPC分类号： A61K31/56 ,  A61K31/57

    摘要： The multiphase combination preparation for oral therapy of dysfunctional uterine bleeding and for oral contraception contains a first phase of 2 daily dosage units, each consisting of 3 mg of estradiol valerate; a second phase of two groups of daily dosage units, which consist of a first group containing 5 daily dosage units, each of which consist of a combination of 2 mg of estradiol valerate and 2 mg of dienogest, and a second group containing 17 daily dosage units, each of which consist of a combination of 2 mg of estradiol valerate and 3 mg of dienogest; a third phase of 2 daily dosage units each consisting of 1 mg of estradiol valerate; and another phase of 2 daily dosage units of a pharmaceutically harmless placebo; so that the multiphase combination preparation consists of a total number of 28 daily dosage units.

    摘要翻译： 用于口服功能障碍性子宫出血和口服避孕药物的多相组合制剂含有2个日剂量单位的第一阶段，每个剂量单位由3mg戊酸雌二醇组成; 两组每日剂量单位的第二期，由含有5个日剂量单位的第一组组成，每组含有2mg戊酸雌二醇和2mg的二烯酸的组合，第二组含有17个日剂量 单位，其中每一个由2mg戊酸雌二醇和3mg的二烯酸的组合组成; 第三阶段为每日2剂量单位，每组1公斤戊酸雌二醇; 另一阶段是药物无害安慰剂的2个日剂量单位; 使多相组合制剂共计28个日剂量单位。

    Method and a playback device for performing a track slip
    10.
    发明授权
    Method and a playback device for performing a track slip 失效
    方法和用于执行轨道滑移的回放装置

    公开(公告)号：US07065007B2

    公开(公告)日：2006-06-20

    申请号：US09937006

    申请日：2001-01-18

    申请人： Holger Zimmermann ,  Volker Becker ,  Jens Maier ,  Dieter Baas

    发明人： Holger Zimmermann ,  Volker Becker ,  Jens Maier ,  Dieter Baas

    IPC分类号： G11B21/08

    CPC分类号： G11B7/08588 ,  G11B7/08505

    摘要： A method for performing a track skip and a playback device for optical storage disks enable an accelerated track skip in the case of a non-moving storage disk in which a time is determined for the track skip of a read device between a current track and a selected track of a storage disk inserted in the playback device, as a function of the tracks to be skipped in this instance, and the read device is moved in the direction of the selected track for the determined time. In response to a track skip request, the read device is moved in the direction of a lead-in area of the optical storage disk until a starting position is detected. The time necessary for the track skip from starting position to the selected track is determined from this track.

    摘要翻译： 用于执行光盘存储盘的轨道跳过和重放装置的方法使得能够在不移动存储盘的情况下加速轨道跳跃，其中确定了当前轨道和当前轨道之间的读取装置的轨迹跳过时间 根据在这种情况下要跳过的轨道的功能，插入回放设备中的存储盘的所选轨道，并且读取设备沿所选择的轨道的方向移动所确定的时间。 响应于轨道跳过请求，读取设备沿光存储盘的导入区域的方向移动，直到检测到起始位置。 从该轨迹确定轨道从起始位置跳到所选轨道所需的时间。